Catalyst overview
Research summary
This catalyst tracks a Phase 1/2 data readout for mRNA-2808 in Multiple Myeloma. The expected timing is based on the latest available company guidance and may change.
11/3/25- First patient dosed. 11/06/25:- PR No update. 04/21/26:- Ph1/2 mRNA-2808 R/R multiple myeloma study poster at ASCO 2026 on June 1.
Verification
Confirm timing and program details against the company announcement or filing.